JEANINE PIRRO (HOST): I want to ask you about something that's been in the news for the last few days and that is the whole idea of the hydrochloroquine and Z-Pak and I understand that, you know that this is not something that's gotten F.D.A. approval for individuals who are -- who now have the coronavirus, but is it available for those who want to be able to use it until we get to the point where we get a cure or at least a vaccine?
BEN CARSON (SECRETARY OF HOUSING AND URBAN DEVELOPMENT): Well, you know, these are prescription drugs, and that they've been utilized for many, many years. With hydrochloroquine, it has been used for malaria for decades. But it hasn't been used in this particular context. And I think that's where you know, there have been some who have tried to gin up a big fight between the President and Dr. Fauci when there really is no room for a fight. There is simply that Dr. Fauci is saying, we don't have the data to prove over the long term that this is effective and totally safe in this setting. And the President is saying, you know, by the time we get that data, it'll be too late for a lot of people and we know that it has been used in lots of settings safely. So let's maybe take a little more risk because we get a lot more upside and that's sort of the difference between a business person and a scientist.
PIRRO: A scientist, right.
CARSON: For scientists, everything has to be point, point, point, point.
CARSON: And with the business person, you know, it's, you know, it's weighing this versus that.
PIRRO: Well, yes, it's really a benefit. I mean, if you go through all the phases of review, I mean, the person who has the virus could be dead, but so, you know, given that the administration and President Trump believes in the right to try, well, this is now something where, you know, there is a certain compassionate ability, at least to get this stuff.